Impact of Liquid Biopsy on the Therapeutic Pathway for Lung Cancer: Advancing the Molecular Characterization of Patients With Advanced Lung Adenocarcinoma by Integrating Liquid Biopsy Into the Early Stages of the Diagnostic and Therapeutic Pathway

NCT07649629 · clinicaltrials.gov ↗

RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Advanced Non-small Cell Lung Cancer (NSCLC)

Interventions

DIAGNOSTIC_TEST: Plasma-based liquid biopsy

Sponsor

Regina Elena Cancer Institute